Financial Perspectives’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.2K Hold
135
0.01% 328
2026
Q1
$39.5K Hold
135
0.01% 342
2025
Q4
$47.3K Hold
135
0.01% 321
2025
Q3
$43.6K Hold
135
0.01% 329
2025
Q2
$52.5K Hold
135
0.02% 300
2025
Q1
$58.7K Hold
135
0.02% 279
2024
Q4
$49.8K Buy
+135
New +$56.5K 0.02% 302
2024
Q1
Sell
-17
Closed -$8.02K 683
2023
Q4
$8.02K Buy
17
+1
+6% +$462 ﹤0.01% 499
2023
Q3
$6.97K Hold
16
﹤0.01% 489
2023
Q2
$7.11K Hold
16
﹤0.01% 480
2023
Q1
$7.36K Hold
16
﹤0.01% 477
2022
Q4
$8.21K Hold
16
﹤0.01% 459
2022
Q3
$7.27K Hold
16
﹤0.01% 469
2022
Q2
$7.72K Hold
16
﹤0.01% 470
2022
Q1
$7.86K Hold
16
﹤0.01% 491
2021
Q4
$7.42K Hold
16
﹤0.01% 468
2021
Q3
$5.96K Hold
16
﹤0.01% 493
2021
Q2
$6.11K Hold
16
﹤0.01% 512
2021
Q1
$5.74K Hold
16
﹤0.01% 492
2020
Q4
$5.14K Hold
16
﹤0.01% 473
2020
Q3
$4.3K Hold
16
﹤0.01% 437
2020
Q2
$4.21K Hold
16
﹤0.01% 422
2020
Q1
$3.63K Hold
16
﹤0.01% 409
2019
Q4
$4.83K Buy
+16
New +$4.4K ﹤0.01% 399

Other funds holding ELV

Financial Perspectives's ELV Position: Q2 2026 in Review

Financial Perspectives held its Elevance Health (ELV) position steady in Q2 2026 at 135 shares worth $52.2K. The position accounts for 0.01% of the portfolio, ranked #328.

Financial Perspectives first reported a position in ELV in Q4 2019 and has held it in 24 quarters since. The position peaked at $58.7K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Financial Perspectives held 135 shares of Elevance Health worth $52.2K as of Q2 2026.
  • Financial Perspectives left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.01% of Financial Perspectives's portfolio in Q2 2026, its #328 holding.
  • Financial Perspectives first reported a position in Elevance Health in Q4 2019 and has held it in 24 quarters since.
  • Financial Perspectives's Elevance Health position peaked at $58.7K in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.